Clinical trial
Long-Term Safety and Tolerability of ABT-126 in Subjects with Mild-to-Moderate Alzheimer�s Disease: An Open-Label Extension Study for Subjects Completing Study M10-985.
The objective of this study is to evaluate the long-term safety and tolerability of ABT-126 in subjects with mild-to-moderate AD in a 28-week, open-label extension of Study M10-985.
| Category | Value |
|---|---|
| Study start date | 2012-05-15 |